Global X Genomics & BiotechnGNOMETF
13F holders, Q3 2025 (September 30)4holders −47
1new positions
15sold out
$10.43avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Global X Genomics & Biotechn (GNOM) in their 13F filings, down 47 from Q2 2025. 1 opened new positions and 15 sold out. The largest holders were IFP Advisors, Inc ($21K), Osaic Holdings, Inc. ($3K) and Global Retirement Partners, LLC ($3K).
- Company
- Global X Genomics & Biotechn
- CUSIP
- 37954Y434
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 15 | $2.4M |
All 13F filers, Q2 2025 → Q3 2025: 44 shares bought and 288,003 shares sold, net −287,959 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| IFP Advisors, Inc | 0.00% | Reduce -3.2% | 2,270 | $21K |
| Osaic Holdings, Inc. | 0.00% | Reduce -40.5% | 330 | $3K |
| Global Retirement Partners, LLC | 0.00% | Reduce -75.1% | 70 | $3K |
| Blue Trust, Inc. | 0.00% | New | 44 | $2K |
"% of holder's portfolio" is GNOM's weight in each manager's 13F, not the share of Global X Genomics & Biotechn the manager owns.